Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Akaza

Showing results (221-230 of 293) with videos related to

Pageof 30
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1991
[Clinical phase III study on TAP-144-SR, an LH-RH agonist depot formulation, in patients with prostatic cancer]Y Aso, S Kameyama, T Niijima, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 1, 1988
[Five-year trend in new patients with prostatic carcinoma]N Moriyama, H Akaza, M Sugimoto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladderA Maru, H Akaza, S Isaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1986
[Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group]T Niijima, T Koyanagi, S Sakashita, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research GroupH Akaza, S Isaka, K Koiso, et al.
Japanese Journal of Clinical Oncology|January 23, 1998
A case of intravascular papillary endothelial hyperplasia (Masson's tumor) arising from renal sinusA Johraku, N Miyanaga, N Sekido, et al.
International Journal of Cancer|November 14, 1997
Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinomaT Shimazui, P P Bringuier, H van Berkel, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 1, 1992
[Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors]T Niijima, H Akaza, T Koyanagi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1993
[Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study]Y Aso, H Akaza, K Koiso, et al.
Japanese Journal of Clinical Oncology|May 8, 2000
Early results of LH-RH agonist treatment with or without chlormadinone acetate for hormone therapy of naive localized or locally advanced prostate cancer: a prospective and randomized study. The Prostate Cancer Study GroupH Akaza, Y Homma, K Okada, et al.
Pageof 30

Showing results (221-230 of 293) with videos related to

Sort By:
Pageof 30
Hinyokika Kiyo. Acta Urologica Japonica|March 1, 1991
[Clinical phase III study on TAP-144-SR, an LH-RH agonist depot formulation, in patients with prostatic cancer]Y Aso, S Kameyama, T Niijima, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 1, 1988
[Five-year trend in new patients with prostatic carcinoma]N Moriyama, H Akaza, M Sugimoto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladderA Maru, H Akaza, S Isaka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1986
[Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group]T Niijima, T Koyanagi, S Sakashita, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research GroupH Akaza, S Isaka, K Koiso, et al.
Japanese Journal of Clinical Oncology|January 23, 1998
A case of intravascular papillary endothelial hyperplasia (Masson's tumor) arising from renal sinusA Johraku, N Miyanaga, N Sekido, et al.
International Journal of Cancer|November 14, 1997
Decreased expression of alpha-catenin is associated with poor prognosis of patients with localized renal cell carcinomaT Shimazui, P P Bringuier, H van Berkel, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 1, 1992
[Combination therapy with natural type human tumor necrosis factor (MHR-24) and human lymphoblastoid interferon-alpha (MOR-22) against renal cell carcinoma--a multiclinic cooperative, early phase II study. Subcommittee on Urogenital Malignancy, Committee on MHR-24 against Tumors]T Niijima, H Akaza, T Koyanagi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 1, 1993
[Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study]Y Aso, H Akaza, K Koiso, et al.
Japanese Journal of Clinical Oncology|May 8, 2000
Early results of LH-RH agonist treatment with or without chlormadinone acetate for hormone therapy of naive localized or locally advanced prostate cancer: a prospective and randomized study. The Prostate Cancer Study GroupH Akaza, Y Homma, K Okada, et al.
Pageof 30